1 withdrawn. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Pulmonary Emphysema: new trials by email Literature Review of Pulmonary Emphysema trials Research Report on Pulmonary Emphysema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema Mesenchymal stem cells, Reference therapy: 400 mL of 0.9% NaCl solution - Pulmonary Emphysema | Phase 1 / Phase 2 | Withdrawn | Federal Research Clinical Center of Federal Medical & Biological Agency, Russia | 2014-03-01 | 2018-01-09 |
Chronic Disease (1) · Disease Attributes (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pulmonary Disease, Chronic Obstructive (1) · Respiratory Tract Diseases (1) · Signs and Symptoms (1) · Signs and Symptoms, Respiratory (1)
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia (1)
Russia (1)